Medical Imaging Markets Volume IV Contrast Agents

Chapter One: Executive Summary

1.1 The Role of Contrast
1.2 Use by Modality
1.2.1 X-Ray and CT
1.2.2 Ultrasound
1.2.3 MRI
1.2.4 Radiopharmaceuticals

1.3 World Market Summary
1.3.1 Market Drivers
1.3.2 Market Challenges
1.3.3 World Market Growth Analysis


1.4 Methodology

Chapter Two: Introduction
2.1 Overview
2.2 Perspective
2.3 Key Markets for Contrast Agents
2.3.1 Radiography (X-Ray) and Computed Tomography (CT)
2.3.2 Ultrasound
2.3.3 Magnetic Resonance Imaging (MRI)
2.3.4 Nuclear Medicine
2.3.4.1 Positron Emission Tomography (PET)
2.3.4.2 Single Photon Emission Computed Tomography SPECT
2.3.4.3 Gamma Cameras


2.4 Ionic and Non-Ionic Contrast Agents
2.5 Issues and Challenges
2.5.1 Adverse Events
2.5.2 Therapeutic Monitoring
2.5.3 Drug Delivery and Image Guided Interventions
2.5.4 Whole Body Screening
2.5.5 Technology Development
2.5.6 Combination Technology

Chapter Three: Promising Developments
3.1 Nuclear Imaging for Appendicitis
3.2 PET for Alzheimer’s
3.3 Contrast-Enhanced MRI Mammogram
3.4 Combined Contrast Enhanced MRI
3.5 Contrast Angiography
3.6 Avoiding Multiple MRIs
3.7 Chemical Shift Imaging
3.8 Perfusion CT
3.9 Multimodal Contrast

Chapter Four: Markets
4.1 Market Drivers
4.1.1 Targeted Imaging
4.1.2 The Promise of Increased Diagnostic Efficacy
4.1.3 Older Population
4.1.4 System Upgrades


4.2 Procedures and Reimbursement
4.3 Market Size and Outlook for Contrast Media
4.3.1 Agents in Development
4.3.2 Total Market Size and Forecast
4.3.3 Segment Market Forecasts
4.3.3.1 Radiography (X-Ray)
4.3.3.2 Computed Tomography (CT)
4.3.3.3 Ultrasound
4.3.3.4 Magnetic Resonance Imaging (MRI)


4.4 Market Size and Outlook for Molecular Imaging Agents
4.4.1 Products and Development
4.4.2 Market Forecast


4.5 Competitive Positions
 
Chapter Five: Company Profiles
Acusphere Inc.
Advanced Magnetics Inc.
ART Advanced Research Technologies Inc.
Bristol-Myers Squibb
Boston Life Sciences
Bracco SpA
Cell Point
Cytogen Corp.
Daiichi Pharmaceutical Co. Ltd.
Dendritic NanoTechnologies Inc.
Dowpharma
Draximage
Epix Pharmaceuticals Inc.
E-Z-EM Inc.
GE Healthcare
Guerbet Group
Hovione FarmaCiencia SA
Imcor Pharmaceutical Co.
Immunomedics Inc.
King Pharmaceuticals Inc.
Luna nanoWorks
Macrocyclics
Mallinckrodt
Palatin Technologies Inc.
Pharmacyclics
Point Biomedical Corp.
Schering AG


List of Exhibits

Chapter One: Executive Summary


Exhibit 1: Market Summary: World Market for Medical Contrast Media 2006-2010

Chapter Two: Introduction
Exhibit 2: Key Medical Contrast Agents by Type
Exhibit 3: Advantages of Non-Ionic Contrast Media

Chapter Four: Markets
Exhibit 4: Estimated Worldwide Medical X-Ray Procedure Volume by Region (U.S., E.U., ROW) 2005
Exhibit 5: Estimated Worldwide Medical MRI Procedure Volume by Region (U.S., E.U., ROW) 2005
Exhibit 6: Estimated Worldwide Medical CT Procedure Volume by Region (U.S., E.U., ROW) 2005
Exhibit 7: Estimated Worldwide Medical PET Procedure Volume by Region (U.S., E.U., ROW) 2005
Exhibit 8: Estimated Percentage of Imaging Procedures Employing Contrast Agents by Modality (X-Ray, CT, MRI, Ultrasound, PET, SPECT)
Exhibit 9: Status of Selected Medical Imaging Agents in Development (Company, Product, Status)
Exhibit 10: World Market for Medical Contrast Media and Radiopharmaceuticals 2005-2010
Exhibit 11: World Market Share for Medical Contrast Media and Radiopharmaceuticals by Modality (CT, MRI, PET, SPECT, Ultrasound, X-Ray), 2006
Exhibit 12: World Market Share for Medical Contrast Media and Radiopharmaceuticals by Modality (CT, MRI, PET, SPECT, Ultrasound, X-Ray), 2010
Exhibit 13: World Market for X-Ray Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
Exhibit 14: World Market for Medical X-Ray Contrast Media by Geographic Segment
Exhibit 15: World Market for CT Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
Exhibit 16: World Market for Medical CT Contrast Media by Geographic Segment
Exhibit 17: World Market for Ultrasound Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
Exhibit 18: World Market for Medical Ultrasound Contrast Media by Geographic Segment
Exhibit 19: World Market for MRI Contrast Media by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
Exhibit 20: World Market for Medical MRI Contrast Media by Geographic Segment
Exhibit 21: World Market for PET Radiopharmaceuticals by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
Exhibit 22: World Market for Medical PET Radiopharmaceuticals by Geographic Segment
Exhibit 23: World Market for SPECT Radiopharmaceuticals by Geographic Segment (U.S., Europe, Japan, ROW) 2005-2010
Exhibit 24: World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment
Exhibit 25: Key Players’ Shares of the Worldwide Medical Contrast Media Market, 2005